Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
5,301	72.59698	1	male	0	46	136	MOSF w/Malig	ARF/MOSF	2	8	$25-$50k	9	114,631	null	null	21.5	white	37	103	0.181	0.092987	18	1	0	yes	0.8	0.5	no dnr	46	128	10.798828	115	12	36.89844	292.5	3.199707	1.699951	0.599976	146	7.40918	279	24	4,000	0	1	adl>=4 (>=5 if sur)	1
5,302	70.125	1	female	0	22	366	MOSF w/Malig	ARF/MOSF	2	13	under $11k	9	89,992	null	null	40.666657	black	32.796875	63	0.305969	0.19397	2	1	0	metastatic	0.7	0.4	no dnr	22	62	13.898438	70	32	36.39844	155	null	null	0.699951	132	7.449219	85	19	2,980	null	0	no(M2 and SIP pres)	0
5,303	46.612	1	female	0	38	140	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	139,684	null	null	31	white	29.796875	62	0.606934	0.500977	7	0	0	metastatic	0.8	0.6	no dnr	38	105	3.599609	100	24	37.5	null	null	0.299988	1	143	null	93	11	2,400	null	0	null	0
5,304	42.56799	1	female	0	47	53	MOSF w/Malig	ARF/MOSF	2	15	$11-$25k	0	90,541	54,508.6875	51,188	16.25	black	25.199219	40	0.703979	0.61499	1	0	0	yes	1	1	no dnr	47	63	4.899414	105	24	35.89844	null	null	3.699707	1.199951	137	null	113	34	null	0	0	<2 mo. follow-up	0
5,305	41.60699	0	male	0	32	587	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	37	null	null	null	20.5	white	36.09375	88	0.333984	0.218994	16	0	0	yes	0.75	0.75	no dnr	32	73	8.099609	114	28	36.5	291.375	3.899902	0.599976	0.5	139	7.319336	80	9	2,050	null	2	no(M2 and SIP pres)	2
5,306	48.71698	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	under $11k	0	64,982	36,829.125	34,040	46	black	48.59375	54	0.269958	0.162994	3	0	0	no	0.4	0.2	dnr after sadm	8	68	11.199219	65	10	35.29688	395.1875	2.099609	13.699219	6.899414	142	7.339844	231	120	160	null	1	<2 mo. follow-up	1
5,307	43.00598	1	male	0	12	147	MOSF w/Malig	ARF/MOSF	1	9	$25-$50k	26	35,825	22,253.6562	24,001	17.5	white	36.59375	64	0.199982	0.106995	6	0	0	yes	null	null	no dnr	12	99	10.798828	72	20	37.39844	null	2.699707	0.399963	1.199951	128	null	102	17	6,150	0	0	no(M2 and SIP pres)	0
5,308	82.52399	1	female	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	1	18	$25-$50k	44	35,284	21,131.6719	19,206	31.5	black	32.796875	38	0.314941	0.201996	1	0	1	no	0.4	0.3	no dnr	12	73	6.699219	76	20	36.09375	null	3.799805	1.299805	1.299805	136	null	86	16	2,300	null	null	<2 mo. follow-up	4.921875
5,309	44.57199	0	female	0	14	584	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	26	53,322	33,376.5625	33,202	27.333328	white	28.597656	36	0.737915	0.655884	1	0	0	no	0.7	0.6	no dnr	14	63	16.699219	115	22	37.69531	157.125	1.899902	4.699219	0.399963	135	7.439453	100	13	2,675	5	1	SIP>=30	1
5,310	69.72998	0	male	0	14	584	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	0	51,703	29,591.9531	31,750	14.666664	white	24.199219	33	0.738892	0.657959	1	0	0	yes	0.95	0.93	no dnr	14	52	8	65	24	36.19531	null	3.699707	1	1	135	null	114	11	1,950	null	null	null	2.767578
5,311	53.72998	1	female	0	4	492	Lung Cancer	Cancer	1	12	under $11k	0	null	2,964.75	2,813	13	black	14.798828	15	0.770996	0.524902	1	0	0	metastatic	0.8	0.6	no dnr	4	97	13.099609	106	32	36.59375	133.3125	null	null	1	135	7.289062	159	40	1,200	null	null	no(M2 and SIP pres)	1.962891
5,312	68.91699	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	$11-$25k	0	87,973	46,006.25	46,716	33	white	34.59375	59	0.471985	0.352966	14	0	0	no	0.25	0.5	dnr after sadm	7	123	1.5	185	26	38	280	null	2.5	1	141	7.459961	136	40	1,220	null	null	<2 mo. follow-up	3.089356
5,313	68.211	1	male	0	56	72	COPD	COPD/CHF/Cirrhosis	2	null	null	0	120,387	74,504.75	74,446	18.5	white	27.699219	30	0.736938	0.587891	1	1	0	no	0.8	0.8	dnr after sadm	41	70	13.699219	70	22	36.19531	153.3125	null	null	0.899902	140	7.439453	102	21	null	null	null	null	2.660156
5,314	78.79297	1	female	1	7	7	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	41	77,543	46,027.3438	46,290	14.5	black	29.097656	72	0.263977	0.15799	15	1	0	yes	0.2	0.1	dnr after sadm	2	70	3.099609	115	42	38.19531	157.5	null	null	3	133	7.5	115	66	680	null	null	<2 mo. follow-up	3.062012
5,315	58.86099	1	male	0	4	223	Lung Cancer	Cancer	2	10	$25-$50k	0	6,491	3,419.3613	1,940	9	white	13.798828	19	0.778931	0.537964	1	0	0	metastatic	0.9	0.7	no dnr	4	105	2.199707	135	32	38.29688	280	null	1.5	4.799805	127	7.30957	446	102	282	0	0	no(M2 and SIP pres)	0
5,316	61.19598	0	female	0	29	582	ARF/MOSF w/Sepsis	ARF/MOSF	1	17	$25-$50k	0	null	39,673.9688	41,995	15.5	black	25.5	47	0.79895	0.73291	1	1	0	no	0.7	0.7	no dnr	29	0	19.796875	0	0	38.39844	148	2.099609	null	0.5	128	7.399414	132	10	1,710	0	0	no(M2 and SIP pres)	0
5,317	66.22296	1	male	0	41	204	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	under $11k	41	85,318	52,149.25	65,274	30	black	18.398438	43	0.777954	0.705933	1	0	0	no	0.25	0.2	no dnr	41	58	16.296875	105	28	36	158	1.599854	5.699219	3.699707	130	7.349609	30	35	70	null	null	no(M2 and SIP pres)	2.446289
5,318	49.54999	0	female	0	15	582	Lung Cancer	Cancer	1	12	under $11k	0	11,291	8,300.6562	9,814	6.666664	white	13.398438	8	0.799927	0.575928	1	0	0	metastatic	0.9	0.7	no dnr	15	52	7.299805	81	24	36.59375	null	null	0.699951	0.899902	139	null	88	12	null	0	0	no(M2 and SIP pres)	0
5,319	26.10799	1	female	1	19	19	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	0	null	32,633.625	32,219	16	black	22.296875	50	0.650879	0.55188	10	0	0	metastatic	0.4	0.1	dnr after sadm	5	155	9.298828	50	26	35.5	409.5	3.099609	null	1.799805	147	7.459961	139	43	2,195	null	null	<2 mo. follow-up	2.739258
5,320	61.73898	1	male	1	8	8	Coma	Coma	0	16	$25-$50k	100	28,443	17,677.4062	17,837	26	white	21.5	27	0.30896	0.237976	1	0	0	no	0	0	dnr after sadm	5	49	41.296875	50	7	38.09375	106	null	24.796875	3.699707	135	7.399414	299	41	20	null	0	<2 mo. follow-up	0
5,321	69.01599	1	female	1	21	21	Coma	Coma	2	4	under $11k	44	null	23,308.2031	24,254	19.666656	black	27	52	0.365967	0.292969	1	1	0	no	0	0	dnr after sadm	7	78	25.097656	155	32	38.5	203.3125	2.299805	0.5	5.599609	138	7.459961	310	91	0	null	1	<2 mo. follow-up	1
5,322	72.66797	1	male	0	4	177	CHF	COPD/CHF/Cirrhosis	3	14	under $11k	26	null	4,063.8418	3,017	12	white	34.5	31	0.435974	0.234985	1	1	0	no	0.5	0.4	dnr after sadm	2	127	18.097656	125	29	36	260	2	1.099854	0.799927	123	7.529297	364	36	1,462	7	7	adl>=4 (>=5 if sur)	7
5,323	67.461	0	female	0	22	579	Colon Cancer	Cancer	1	12	null	0	null	32,987.5625	29,834	24.333328	white	32.898438	26	0.469971	0.153992	1	0	0	metastatic	null	null	no dnr	22	79	10	74	20	36.5	null	4.099609	0.599976	1	143	null	112	9	4,550	0	0	no(M2 and SIP pres)	0
5,324	76.96399	0	male	0	20	577	ARF/MOSF w/Sepsis	ARF/MOSF	2	7	$11-$25k	9	null	25,542.1406	28,982	14	black	27.699219	44	0.589966	0.480957	1	1	0	yes	null	null	no dnr	20	73	4.5	80	24	36.19531	null	3.699707	0.599976	1	138	null	233	9	3,875	3	0	null	0
5,325	52.20499	0	female	0	36	577	ARF/MOSF w/Sepsis	ARF/MOSF	0	7	under $11k	44	86,035	53,994.6562	61,818	25.75	black	26.398438	49	0.681885	0.588989	1	0	0	no	0.5	0.5	no dnr	36	62	7.799805	70	16	36.79688	null	2.299805	1.399902	1.399902	135	null	90	17	1,800	null	0	null	0
5,326	67.94495	1	male	0	27	223	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	under $11k	0	97,439	54,870.0625	59,514	32.25	white	19.199219	25	0.828979	0.770996	5	0	0	no	0.5	0.3	dnr after sadm	5	107	8.699219	80	20	37.5	null	null	0.399963	1	140	null	83	6	2,840	null	0	adl>=4 (>=5 if sur)	0
5,327	68.99695	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	14	null	0	94,104	52,377.1875	47,141	48	white	43.796875	79	0.192993	0.102997	22	0	0	no	0.8	0.8	no dnr	4	98	6.399414	65	20	35.89844	304.75	null	0.699951	3.799805	139	7.419922	88	115	2,575	null	null	<2 mo. follow-up	2.287109
5,328	89.82098	0	female	0	19	577	Coma	Coma	1	12	under $11k	55	null	null	null	11.333328	black	15.298828	12	0.436951	0.363953	1	0	0	no	0.6	0.6	dnr after sadm	1	115	1.799805	75	29	35.39844	160	2.899902	0.899902	1.5	134	7.439453	110	43	5,860	null	1	adl>=4 (>=5 if sur)	1
5,329	63.159	1	male	1	17	17	Coma	Coma	0	7	under $11k	55	null	57,245.75	58,565	42.666657	black	31.097656	41	0.202972	0.141998	3	0	0	no	0.2	0.2	dnr after sadm	17	112	19	0	28	36.5	352.375	4.099609	0.399963	1.099854	138	7.429688	171	22	2,790	null	6	<2 mo. follow-up	6
5,330	72.81897	1	male	0	7	73	Lung Cancer	Cancer	1	20	>$50k	0	6,116	4,265.1016	4,535	5.5	white	25.898438	18	0.464966	0.149994	1	0	0	metastatic	0.8	0.6	dnr after sadm	2	120	40	115	26	35.19531	360	1.899902	1	1.199951	137	7.389648	111	13	2,405	1	2	adl>=4 (>=5 if sur)	2
5,331	43.34598	1	female	0	5	403	Lung Cancer	Cancer	1	14	>$50k	0	12,808	6,627.9453	4,023	12	white	14.199219	12	0.799927	0.575928	1	0	0	metastatic	0.9	0.6	no dnr	5	90	6.199219	64	20	36.59375	130	null	null	1.799805	138	7.389648	109	28	4,315	0	null	no(M2 and SIP pres)	0.494751
5,332	80.58295	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	0	null	21,836.2969	19,572	21	white	20.699219	27	0.697998	0.60791	1	0	0	metastatic	0	0	dnr after sadm	3	125	13.599609	145	20	39.5	86.14062	3.099609	0.599976	1.799805	155	7.319336	210	46	2,920	null	null	<2 mo. follow-up	2.748535
5,333	42.24197	1	male	1	22	22	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	$25-$50k	0	null	null	null	40.666657	black	49.296875	83	0.312988	0.199982	2	0	0	no	0.3	0.25	dnr after sadm	16	63	null	70	32	37.89844	196.65625	2	null	0.799927	135	7.399414	103	8	4,150	null	0	<2 mo. follow-up	0
5,334	66.82794	1	female	0	115	244	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	445,984	null	null	41	white	31.398438	79	0.563965	0.451965	20	0	0	no	0.5	0.4	no dnr	115	58	5.899414	60	22	36.09375	136.71875	null	null	1	138	7.349609	100	13	1,760	null	null	Coma or Intub	2.143555
5,335	70.69397	1	female	1	19	19	MOSF w/Malig	ARF/MOSF	1	12	null	0	null	null	null	45.666657	white	27.097656	45	0.596924	0.488953	2	0	0	yes	0.9	0.8	dnr after sadm	10	78	12.199219	78	24	36.5	null	null	0.299988	1	141	null	112	24	1,150	null	0	<2 mo. follow-up	0
5,336	65.71698	0	male	0	6	575	Cirrhosis	COPD/CHF/Cirrhosis	1	11	under $11k	9	6,897	4,673.8594	4,331	9	black	24.898438	41	0.622925	0.437988	1	0	0	no	null	null	no dnr	6	30	10.398438	180	33	36.09375	350	2.599609	0.199982	0.599976	120	7.55957	224	4	7,360	0	0	no(M2 and SIP pres)	0
5,337	64.07397	1	female	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	280,170	158,999.875	159,265	40.5	white	33.5	60	0.511963	0.394958	53	0	0	no	0.1	0.1	dnr after sadm	7	50	24.898438	115	27	35.79688	438.0625	null	0.5	5.199219	147	7.429688	272	41	705	null	null	<2 mo. follow-up	2.162598
5,338	74.20898	1	male	1	12	12	ARF/MOSF w/Sepsis	ARF/MOSF	1	0	$11-$25k	0	null	null	null	54	white	42	70	0.211975	0.115997	19	0	0	no	0.2	0.2	no dnr	12	99	7.5	70	16	36.19531	null	3.599609	0.699951	1.199951	139	null	91	8	2,525	null	null	<2 mo. follow-up	2.253906
5,339	67.896	1	male	0	9	92	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	100	null	13,553	15,362	24.5	white	27.199219	45	0.291992	0.181	1	1	0	no	0.5	0.5	no dnr	9	113	9.699219	95	16	35.79688	null	4	0.599976	0.799927	138	null	92	7	6,600	null	0	adl>=4 (>=5 if sur)	0
5,340	61.77698	0	female	0	16	573	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	0	86,438	48,095.8125	53,617	28.333328	white	27.5	27	0.75	0.670898	2	0	0	no	null	null	no dnr	16	110	22.699219	110	8	38.39844	185.6875	null	0.599976	1.099854	131	7.449219	164	14	2,700	null	0	no(M2 and SIP pres)	0
5,341	68.99896	1	male	0	4	474	COPD	COPD/CHF/Cirrhosis	5	3	under $11k	0	7,860	5,247.0859	4,711	14	black	30.199219	29	0.681885	0.511963	1	1	0	no	0.6	0.4	no dnr	4	65	8.199219	65	23	37	138.75	null	5.599609	0.899902	139	7.489258	121	23	4,140	3	3	adl>=4 (>=5 if sur)	3
5,342	28.75299	0	female	0	9	572	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	9	null	null	null	14	white	26.796875	17	0.858887	0.809937	1	0	0	no	1	1	no dnr	9	25	14.599609	0	12	37.39844	368	2.5	19.5	1.5	150	7.419922	85	25	2,305	null	null	null	3.20459
5,343	75.99695	1	male	1	10	10	MOSF w/Malig	ARF/MOSF	1	8	$11-$25k	0	null	38,309.9688	35,311	46	white	29.398438	60	0.356995	0.23999	14	0	0	metastatic	0.05	0	dnr after sadm	1	82	24.699219	105	12	36	null	null	0.099991	1.299805	134	null	84	28	1,460	null	7	<2 mo. follow-up	7
5,344	47.80298	1	male	0	4	114	Cirrhosis	COPD/CHF/Cirrhosis	2	10	under $11k	0	null	2,903.2246	3,018	9	white	20.5	34	0.843994	0.743896	1	0	0	no	null	null	no dnr	4	110	12	115	38	38.5	148.96875	null	null	1	136	7.389648	103	6	4,450	1	null	adl>=4 (>=5 if sur)	1.166748
5,345	53.47299	0	female	0	7	570	Lung Cancer	Cancer	2	16	>$50k	0	null	7,263.5156	4,564	7.5	white	17.097656	2	0.731934	0.461975	1	0	0	metastatic	null	null	no dnr	7	75	9.699219	70	24	37.79688	256.625	null	null	1.599854	147	7.459961	136	38	3,400	0	1	no(M2 and SIP pres)	1
5,346	46.90198	1	male	1	21	21	MOSF w/Malig	ARF/MOSF	3	11	under $11k	0	36,932	24,180.2188	23,668	19.333328	black	32.09375	63	0.533936	0.418945	1	0	0	yes	null	null	no dnr	21	72	9.798828	75	24	38.39844	385.6875	null	0.599976	1.299805	137	7.389648	111	12	1,120	null	7	<2 mo. follow-up	7
5,347	84.60199	1	female	0	14	199	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	null	17,063.7344	17,790	19	white	29.597656	53	0.60498	0.416992	1	0	0	no	0.5	0.45	no dnr	14	118	46.898438	96	26	36.5	null	3.199707	0.5	1.199951	129	null	80	16	2,870	0	0	null	0
5,348	64.48999	0	female	0	16	569	Cirrhosis	COPD/CHF/Cirrhosis	3	12	null	9	null	22,021.2812	22,701	22.666656	white	29	47	0.445984	0.244995	1	0	0	yes	0.5	0.5	no dnr	16	142	0.099991	160	28	34.59375	436	1.5	2	1.5	140	7.489258	333	34	1,345	0	0	no(M2 and SIP pres)	0
5,349	54.81497	1	male	0	5	307	Lung Cancer	Cancer	1	16	>$50k	0	null	6,166.4492	5,415	12	white	11.798828	11	0.814941	0.601929	1	0	0	metastatic	1	0.8	no dnr	5	62	5.199219	135	40	38.5	103.32812	1.5	null	1.699951	143	7.329102	160	26	1,955	null	null	null	1.861572
5,350	47.35397	1	female	0	21	271	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	0	54,872	32,157.9219	34,325	29	white	28.398438	50	0.771973	0.698975	4	1	0	no	0.5	0.5	no dnr	21	60	12.199219	120	31	39.5	115	1.699951	1.099854	0.799927	145	7.519531	295	21	2,570	null	1	SIP>=30	1
5,351	38.70798	1	male	0	65	170	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$25-$50k	9	262,777	null	null	26.75	white	29.199219	73	0.743896	0.662964	10	1	0	no	0.95	0.95	no dnr	65	97	52.296875	104	24	38.5	223.78125	3.199707	4.699219	0.5	134	7.469727	212	13	3,050	1	2	SIP>=30	2
5,352	55.25299	0	male	0	4	568	COPD	COPD/CHF/Cirrhosis	1	null	null	0	null	2,724.9902	3,168	10	white	18.199219	23	0.91394	0.85498	1	0	0	no	null	null	no dnr	4	107	22.699219	175	11	37.89844	226.65625	2.299805	19.398438	6.699219	132	7.399414	167	99	105	null	null	null	2.062988
5,353	76.18896	0	male	0	4	568	COPD	COPD/CHF/Cirrhosis	4	6	under $11k	0	null	3,370.7441	3,742	7	black	19.398438	21	0.770996	0.634888	1	0	0	yes	null	null	no dnr	4	40	15.798828	135	18	38.39844	88.5625	2.199707	5.599609	1.899902	137	7.389648	175	15	3,735	0	null	no(M2 and SIP pres)	0.494751
5,354	58.97897	1	male	0	18	492	Colon Cancer	Cancer	1	16	>$50k	0	30,679	18,150.0938	15,333	8.666664	white	13.898438	9	0.862915	0.69397	1	0	0	metastatic	null	null	no dnr	18	55	1.299805	125	36	36.29688	200	null	1.299805	0.699951	145	7.359375	204	30	3,415	null	0	no(M2 and SIP pres)	0
5,355	71.16998	1	female	0	18	440	MOSF w/Malig	ARF/MOSF	1	15	$25-$50k	9	32,147	null	null	19.666656	white	18.898438	33	0.664917	0.567993	3	0	0	metastatic	0.8	0.6	dnr after sadm	3	138	22.5	110	40	36.39844	242.84375	2.5	0.399963	0.399963	123	7.429688	147	13	1,980	null	0	no(M2 and SIP pres)	0
5,356	76.02698	0	male	0	20	567	MOSF w/Malig	ARF/MOSF	1	20	null	0	28,544	18,567.6094	21,607	13.666664	black	22.796875	41	0.642944	0.541992	1	0	0	metastatic	0.5	0.4	dnr before sadm	-1	123	12.199219	55	26	35.89844	212.5	3.899902	0.599976	3.5	143	7.369141	186	65	3,010	0	3	adl>=4 (>=5 if sur)	3
5,357	59.29099	1	female	1	46	46	ARF/MOSF w/Sepsis	ARF/MOSF	1	3	under $11k	0	191,462	null	null	39	white	38.398438	69	0.540894	0.425964	1	1	0	no	0.7	0.7	dnr after sadm	43	73	6.699219	115	26	35.5	307.375	3.299805	0.599976	0.799927	134	7.459961	294	16	1,700	null	1	<2 mo. follow-up	1
5,358	71.47998	0	male	0	10	565	Colon Cancer	Cancer	1	12	under $11k	0	null	12,923.5781	11,901	23	white	20.699219	27	0.744995	0.482971	1	0	0	metastatic	null	null	no dnr	10	105	2.399902	97	18	38.09375	400	null	null	0.899902	135	7.5	103	9	null	null	2	no(M2 and SIP pres)	2
5,359	69.59094	0	male	0	49	565	Coma	Coma	0	null	null	44	97,424	null	null	27	black	21.597656	19	0.48999	0.417969	2	0	0	no	0.7	0.6	no dnr	49	50	16.5	105	22	38.59375	224	null	null	4	129	7.429688	116	76	370	null	0	SIP>=30	0
5,360	64.93396	0	female	0	9	565	Colon Cancer	Cancer	1	28	>$50k	0	null	11,891.6328	10,836	21	white	18.898438	15	0.789917	0.557983	1	0	0	metastatic	null	null	no dnr	9	120	8	115	7	36.5	213.3125	2.399902	0.299988	0.599976	135	7.439453	252	15	3,820	0	0	no(M2 and SIP pres)	0
5,361	39.52597	1	female	0	39	119	MOSF w/Malig	ARF/MOSF	1	16	>$50k	0	128,410	76,735.625	81,132	34.75	white	31.398438	86	0.565918	0.454956	1	0	0	yes	null	null	no dnr	39	62	7	84	2	36.59375	240	null	3.699707	2.899902	131	7.329102	86	48	234	null	0	SIP>=30	0
5,362	72.64099	1	male	0	10	389	Colon Cancer	Cancer	1	14	$25-$50k	9	null	13,854.9609	13,977	21.5	white	32.296875	14	0.419983	0.116989	1	0	0	metastatic	null	null	no dnr	10	63	5.599609	64	20	36.5	null	3.799805	0.299988	11	140	null	112	11	3,285	0	0	no(M2 and SIP pres)	0
5,363	80.008	1	male	0	16	477	CHF	COPD/CHF/Cirrhosis	2	12	null	0	18,096	11,917.1875	12,747	17	white	16.296875	32	0.85791	0.765991	1	0	0	no	0.5	0.3	dnr after sadm	4	68	20.097656	70	29	35.59375	394.25	2.699707	1.599854	2.399902	137	7.349609	212	49	790	7	6	SIP>=30	6
5,364	77.76294	0	female	0	9	564	COPD	COPD/CHF/Cirrhosis	3	12	null	0	null	5,457.9023	5,890	11	white	25.597656	45	0.705933	0.544922	1	0	0	no	0.8	0.7	no dnr	9	65	46.296875	80	32	38.29688	265	3.199707	0.699951	1.5	133	7.429688	95	24	1,680	0	null	null	0.494751
5,365	84.435	1	female	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	$11-$25k	44	null	null	null	31	white	42.898438	80	0.017998	0.004	60	0	1	no	null	null	dnr after sadm	4	73	7.399414	80	20	36.59375	null	null	0.599976	0.899902	140	null	92	14	2,080	null	0	<2 mo. follow-up	0
5,366	79.71497	1	male	1	40	40	ARF/MOSF w/Sepsis	ARF/MOSF	2	3	under $11k	0	153,976	88,431.3125	84,070	45.25	white	17.296875	32	0.817993	0.756958	5	1	0	no	0.8	0.6	dnr after sadm	35	98	16.199219	119	36	37.89844	280.9375	1.399902	null	1.299805	146	7.389648	84	30	1,042	null	null	<2 mo. follow-up	2.28418
5,367	28.142	0	male	0	152	562	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	0	660,091	null	null	55.75	other	44.59375	81	0.572998	0.461975	1	0	0	no	0.05	0.05	no dnr	152	133	19.296875	115	22	39	362.8125	null	null	1.199951	151	7.529297	134	24	2,232	null	0	adl>=4 (>=5 if sur)	0
5,368	66.70496	1	female	1	4	4	Coma	Coma	1	12	under $11k	100	null	8,884.0078	9,813	25	black	31.699219	53	0.044998	0.022999	1	1	0	no	null	null	dnr after sadm	2	132	11.699219	65	0	36.09375	400	null	null	6.099609	140	7.399414	90	75	1,000	null	0	<2 mo. follow-up	0
5,369	44.85699	0	male	0	31	561	Cirrhosis	COPD/CHF/Cirrhosis	1	12	null	0	121,495	75,694.625	82,343	21.5	white	22.796875	28	0.794922	0.670898	5	0	0	no	0.5	0.45	no dnr	31	52	17.296875	55	18	35.79688	91.65625	null	1.299805	1.199951	134	7.279297	73	14	4,400	null	0	no(M2 and SIP pres)	0
5,370	81.24298	1	male	0	53	72	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	null	9	144,170	86,758.1875	87,433	30	white	21.296875	35	0.658936	0.560913	5	0	0	yes	0.1	0.05	no dnr	53	105	3.5	65	10	34.79688	253.3125	2.199707	0.599976	1.099854	140	7.40918	207	15	null	null	0	null	0
5,371	39.034	1	male	1	9	9	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	100	null	15,246.4141	16,569	29.5	black	28.898438	54	0.44397	0.324951	1	1	0	no	0.2	0.2	dnr after sadm	6	82	13.798828	75	20	36	167.34375	null	null	3.699707	142	7.429688	185	69	200	null	null	<2 mo. follow-up	3.508301
5,372	69.08997	1	male	1	15	15	COPD	COPD/CHF/Cirrhosis	2	3	under $11k	9	62,341	36,025.25	36,720	32.666657	black	15.699219	25	0.873901	0.790894	1	1	0	no	0.7	0.7	dnr after sadm	14	55	12.5	125	0	38.09375	340	2.099609	0.699951	0.899902	137	7.379883	154	11	3,330	null	0	<2 mo. follow-up	0
5,373	74.53296	1	female	1	3	3	CHF	COPD/CHF/Cirrhosis	1	8	under $11k	41	16,283	9,550.2188	10,372	43	white	52.695313	73	0.002	0	1	0	0	yes	0.05	0.02	dnr after sadm	2	105	null	70	8	36.09375	193.3125	null	null	1.199951	132	7.40918	228	31	2,390	null	0	<2 mo. follow-up	0
5,374	67.64398	1	male	1	6	6	ARF/MOSF w/Sepsis	ARF/MOSF	0	14	$25-$50k	44	null	61,174.4688	67,226	51	white	49.09375	102	0.009998	0.002	18	0	0	no	0.1	0.05	dnr after sadm	5	43	29.199219	120	8	38.39844	202	2.399902	5.599609	6.799805	131	7.40918	166	96	890	null	0	<2 mo. follow-up	0
5,375	63.46899	1	male	1	7	7	Lung Cancer	Cancer	3	6	under $11k	0	null	8,803.6562	9,150	12	white	24.296875	23	0.541992	0.218994	1	0	0	metastatic	null	null	dnr after sadm	4	123	7.399414	74	24	36	300	3.899902	0.599976	1	145	7.40918	96	12	1,100	null	null	<2 mo. follow-up	2.740723
5,376	33.77399	0	male	0	23	560	Coma	Coma	1	14	$25-$50k	61	83,227	47,545.5938	48,881	36	white	21.296875	16	0.724976	0.674927	2	0	0	no	0.7	0.8	no dnr	23	82	16.5	115	34	35.69531	195	null	1.799805	2.199707	145	7.40918	119	29	1,535	null	4	null	4
5,377	71.258	1	male	1	5	5	Coma	Coma	2	11	$11-$25k	94	null	10,750.5703	9,085	37	black	15.298828	11	0.425964	0.35199	1	1	0	no	0.1	0.05	dnr after sadm	2	80	10.898438	112	20	34.5	null	3.299805	0.5	1	138	null	108	16	null	null	null	<2 mo. follow-up	2.354981
5,378	59.16998	1	female	1	3	3	MOSF w/Malig	ARF/MOSF	1	null	null	44	null	17,679.9531	17,592	52	black	58.5	101	0	0	7	0	0	yes	0.5	0.2	dnr after sadm	3	77	7.699219	68	18	37.89844	null	null	null	0.699951	141	null	86	7	4,175	null	null	<2 mo. follow-up	2.060547
5,379	67.70197	1	female	1	23	23	ARF/MOSF w/Sepsis	ARF/MOSF	3	8	under $11k	0	78,431	46,890.5938	50,243	28	black	23.097656	41	0.755981	0.678955	10	1	0	no	0.7	0.6	dnr after sadm	19	112	9.099609	105	30	35.89844	207.5	2.599609	0.5	1.199951	142	7.399414	145	45	2,755	null	null	<2 mo. follow-up	2.359863
5,380	22.40099	1	male	1	7	7	Coma	Coma	0	11	$11-$25k	100	28,376	null	null	21.5	black	20.398438	20	0.703979	0.650879	1	0	0	no	0.1	0.05	dnr after sadm	6	40	26.296875	65	20	34	118.5625	null	0.899902	3	134	7.419922	363	27	12	null	0	<2 mo. follow-up	0
5,381	69.65094	1	female	0	28	265	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	under $11k	44	43,552	26,990.4688	30,490	15.75	white	40.296875	67	0.122986	0.054993	1	0	1	yes	0.75	0.65	no dnr	28	55	10.298828	160	10	38	217.125	2.599609	3.699707	6.799805	135	7.349609	66	60	25	null	7	adl>=4 (>=5 if sur)	7
5,382	54.853	1	female	1	34	34	ARF/MOSF w/Sepsis	ARF/MOSF	3	14	$11-$25k	0	390,011	229,951.75	257,862	53.5	white	35.195313	69	0.573975	0.462952	7	1	0	no	0.75	0.7	dnr after sadm	33	57	11.5	125	6	35.69531	310	0.599976	null	0.799927	132	7.389648	78	13	1,005	null	2	<2 mo. follow-up	2
5,383	64.33398	0	male	0	15	555	Cirrhosis	COPD/CHF/Cirrhosis	3	11	under $11k	0	28,800	18,037.4062	18,055	14.666664	white	16.398438	35	0.81897	0.705933	1	0	0	no	0.6	0.3	no dnr	15	116	7.699219	110	28	36.79688	null	0.899902	7.599609	0.899902	145	null	118	17	null	null	0	no(M2 and SIP pres)	0
5,384	73.40198	1	female	1	10	10	Coma	Coma	0	null	under $11k	61	37,878	22,510.1094	24,040	37.5	black	22.199219	23	0.371948	0.297974	1	0	0	no	0.2	0.1	dnr after sadm	8	58	7.699219	105	45	35.69531	87.14062	2	0.399963	0.399963	144	7.40918	142	18	1,320	null	0	<2 mo. follow-up	0
5,385	47.543	1	male	0	4	236	Lung Cancer	Cancer	1	16	null	0	9,912	4,916.1719	2,209	15	white	8.5	12	0.863892	0.696899	1	0	0	metastatic	0.9	0.8	no dnr	4	52	21.5	100	12	39	78.5625	null	4.199219	3.799805	136	7.369141	261	60	135	0	0	no(M2 and SIP pres)	0
5,386	66.17896	0	male	0	5	553	CHF	COPD/CHF/Cirrhosis	2	3	null	0	3,540	2,554.6914	2,990	15	black	17.699219	14	0.880981	0.80188	1	0	0	no	1	1	no dnr	5	72	14.298828	95	29	36.79688	98.32812	null	null	0.799927	142	7.459961	156	31	765	0	null	no(M2 and SIP pres)	0.494751
5,387	66.90497	1	male	0	14	19	Lung Cancer	Cancer	1	15	$25-$50k	0	20,427	13,461.5547	14,506	11	white	25.097656	16	0.507935	0.186981	1	0	0	metastatic	0.4	0.2	no dnr	14	75	10.398438	115	24	37.79688	106.65625	null	null	0.799927	134	7.419922	114	17	2,410	0	null	<2 mo. follow-up	0.494751
5,388	41.35199	0	male	0	33	551	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	157,301	87,189.4375	84,195	32.25	white	23.398438	44	0.85791	0.807983	4	0	0	no	0.1	0.1	no dnr	33	112	8.798828	106	20	36.79688	103.32812	null	null	2.399902	147	7.279297	158	31	2,115	null	null	adl>=4 (>=5 if sur)	1.996094
5,389	61.52798	1	female	1	41	41	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	41	227,499	130,203.062	126,559	47	white	31.898438	39	0.444946	0.325989	4	0	0	no	0.7	0.7	dnr after sadm	35	96	5.299805	104	30	39.29688	172.5	null	1.299805	0.599976	134	7.399414	82	11	3,910	null	1	<2 mo. follow-up	1
5,390	59.38898	1	female	0	6	60	Colon Cancer	Cancer	1	12	>$50k	0	5,506	3,822.9062	4,354	8	hispanic	13.099609	5	0.870972	0.709961	1	0	0	metastatic	0.8	0.5	no dnr	6	127	10.798828	140	35	38.59375	172.5	2.5	0.399963	2.099609	147	7.40918	90	57	3,005	0	0	null	0
5,391	56.31198	1	male	0	15	25	Cirrhosis	COPD/CHF/Cirrhosis	1	12	>$50k	9	46,602	30,916	26,684	18	white	22.398438	28	0.747925	0.602905	1	0	0	no	0.85	0.75	no dnr	15	76	16.296875	100	24	37.5	null	1.899902	4.599609	1.299805	139	null	75	12	980	null	0	<2 mo. follow-up	0
5,392	51.63599	1	female	0	77	230	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	456,885	282,560	278,900	32.75	black	28.398438	48	0.701904	0.612915	84	0	0	no	0.65	0.5	no dnr	77	80	5.099609	72	24	36.59375	null	3.399902	0.5	0.5	139	null	132	1.899902	2,650	null	0	no(M2 and SIP pres)	0
5,393	80.86499	1	female	1	19	19	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	under $11k	0	174,811	98,899.875	99,562	48.666657	black	31.5	51	0.48999	0.371948	10	0	0	no	0.2	0.2	dnr after sadm	17	50	23.898438	78	12	34.79688	383.3125	3.199707	0.399963	5.599609	140	7.469727	129	101	0	null	0	<2 mo. follow-up	0
5,394	62.52197	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	2	16	>$50k	null	null	null	null	null	white	null	null	null	null	1	1	0	no	null	null	null	null	55	13.099609	110	25	35.89844	null	null	null	1.799805	133	null	259	60	3,170	null	0	<2 mo. follow-up	0
5,395	52.68399	1	male	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	0	15	>$50k	0	367,304	null	null	63	white	36.09375	77	0.636963	0.534912	1	0	0	no	0.4	0.4	no dnr	31	72	32.09375	115	25	35.89844	166.65625	2.899902	1.099854	0.799927	143	7.429688	221	38	2,530	null	0	<2 mo. follow-up	0
5,396	65.01599	0	female	0	13	546	COPD	COPD/CHF/Cirrhosis	2	null	null	9	33,672	19,349.9219	22,102	27	black	19.5	37	0.852905	0.756958	1	1	0	no	0.9	0.85	no dnr	13	79	11.099609	86	20	37.39844	null	3.799805	0.799927	0.799927	137	null	109	9	null	2	0	no(M2 and SIP pres)	0
5,397	40.00299	1	male	1	14	14	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	0	81,236	null	null	30.666656	black	35.695313	76	0.650879	0.55188	6	0	0	no	0.5	0.4	no dnr	14	55	13.298828	75	26	36.39844	110.20312	1.699951	null	1.399902	140	7.319336	266	26	3,030	null	6	<2 mo. follow-up	6
5,398	43.168	0	male	0	54	547	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	104,206	63,689.6875	63,891	18	white	24.699219	32	0.861938	0.813965	1	0	0	no	0.85	0.85	no dnr	54	138	20.296875	155	36	38.69531	226.65625	2.699707	8.699219	1.199951	145	7.519531	226	25	3,645	0	0	no(M2 and SIP pres)	0
5,399	70.28094	1	female	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	4	16	null	100	68,397	37,768.3125	41,464	38	white	26.597656	60	0.18399	0.095993	15	0	0	no	0.2	0.1	dnr after sadm	3	83	12.398438	72	20	36	254.53125	null	0.899902	1.5	137	7.379883	251	37	null	null	7	<2 mo. follow-up	7
5,400	63.14899	1	female	0	7	54	Lung Cancer	Cancer	1	12	$11-$25k	0	9,809	5,832.0078	5,343	13	black	25.296875	21	0.514893	0.192993	1	0	0	metastatic	0.6	0.3	no dnr	7	86	13.599609	80	18	36.29688	171.40625	null	0.699951	1	135	7.439453	144	19	null	4	3	<2 mo. follow-up	3

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.